Affiliations 

  • 1 Department of Rheumatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
  • 2 Department of Medicine, University of Tabuk, Tabuk, Saudi Arabia
  • 3 Department of Medicine, King Khalid University, Abha, Saudi Arabia
  • 4 Department of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
  • 5 Department of Medicine, Taibah University, Medina, Saudi Arabia
  • 6 Department of Medicine, King Faisal University, Al Ahsa, Saudi Arabia
  • 7 Department of Medicine, Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia
  • 8 Independent Researcher, MBBS graduate of Faculty of Medicine, SEGi University, Malaysia
Int J Prev Med, 2026;17:106.
PMID: 42921354 DOI: 10.4103/ijpvm.ijpvm_401_25

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) is a common but often overlooked disorder with profound cardiometabolic and neurocognitive consequences. Various studies in Saudi Arabia have reported varying prevalence figures.

OBJECTIVE: To estimate the pooled prevalence of OSA among adults in Saudi Arabia.

METHODS: The systematic review and meta-analysis were carried out between May and August 2025 according to PRISMA 2020 guidelines. Observational studies that described the prevalence of OSA among adults (≥16 years) were considered. Pooled prevalence was computed using a random-effect model with Freeman-Tukey transformation. I2 statistics were used to determine the heterogeneity. Subgroup analysis was undertaken according to population, diagnostic tool, size of the sample, and region.

RESULTS: Thirty-three studies with 18,403 participants were included. The overall pooled prevalence of OSA was 26.96% (95% confidence interval [CI]: 20.98%-33.38%), with high heterogeneity (I 2 = 98.9%). This significant heterogeneity is primarily attributed to variations in study populations (general vs. high-risk) and the diverse diagnostic criteria employed across the included studies. The prevalence was 15.95% (95% CI: 11.80%-20.60%) in the general population and 42.60% (95% CI: 29.47%-56.27%) in high-risk groups. The diagnostic method influenced estimates, with polysomnography (34.1%) and STOP-BANG (33.8%) yielding higher prevalence than the Berlin Questionnaire (28.5%). Regional variation was observed, with higher prevalence in Riyadh compared to Mecca.

CONCLUSIONS: About one in four Saudi adults may have OSA, with prevalence markedly higher in high-risk groups. These findings underscore the need for national screening programs and targeted interventions to reduce the burden of undiagnosed OSA.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications